BR112012026870A2 - assinaturas genéticas e chips de gene associados à administração de frequência de ráfsudio conduzida eletricamente à pele e métodos e tratamentos relacionados aos mesmos - Google Patents

assinaturas genéticas e chips de gene associados à administração de frequência de ráfsudio conduzida eletricamente à pele e métodos e tratamentos relacionados aos mesmos

Info

Publication number
BR112012026870A2
BR112012026870A2 BR112012026870A BR112012026870A BR112012026870A2 BR 112012026870 A2 BR112012026870 A2 BR 112012026870A2 BR 112012026870 A BR112012026870 A BR 112012026870A BR 112012026870 A BR112012026870 A BR 112012026870A BR 112012026870 A2 BR112012026870 A2 BR 112012026870A2
Authority
BR
Brazil
Prior art keywords
skin
gene
mammalian skin
rfsudio
treatments
Prior art date
Application number
BR112012026870A
Other languages
English (en)
Inventor
David John Weisgerber
Nikki Elizabeth Annunziata
Tia Janninne Maurer
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BR112012026870A2 publication Critical patent/BR112012026870A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Abstract

assinaturas genéticas e chips de gene associados à administração de frequência de ráfsudio conduzida eletricamente à pele e métodos e tratamentos relacionados aos mesmos. trata-se do painel de gene que compreende genes regulados na pele de mamíferos em resposta à geração de uma corrente de frequência de rádio em um volume de tecido da pele de mamífero suficiente para aquecer o volume de tecido a uma temperatura de tratamento, em que pelo menos um gene é selecionado a partir da tabela 1 ou da tabela 2 e pelo menos um gene é selecionado a partir da tabela 3. ademais, existe um método para fornecer um benefício para a pele de mamíferos, em que o benefício compreende induzir a formação de colágeno e/ou a remodelagem dérmica em uma camada dérmica da pele de mamífero na ausência de uma resposta de citoquina inflamatória denificadora da pele, sendo que o método compreende gerar uma corrente de frequência de rádio em um volume de tecido da pele de mamífero por um ciclo de tratamento suficiente para aquecer o volume de tecido a uma temperatura de tratamento enquanto se evita uma regulação ascendente na expressão dos genes listados na tabela 3.
BR112012026870A 2010-04-19 2011-04-19 assinaturas genéticas e chips de gene associados à administração de frequência de ráfsudio conduzida eletricamente à pele e métodos e tratamentos relacionados aos mesmos BR112012026870A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32563310P 2010-04-19 2010-04-19
PCT/US2011/033033 WO2011133538A1 (en) 2010-04-19 2011-04-19 Genetic signatures and gene chips associated with administration of electrically conducted radio frequency current to skin and methods and treatments relating thereto

Publications (1)

Publication Number Publication Date
BR112012026870A2 true BR112012026870A2 (pt) 2017-01-10

Family

ID=44343224

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012026870A BR112012026870A2 (pt) 2010-04-19 2011-04-19 assinaturas genéticas e chips de gene associados à administração de frequência de ráfsudio conduzida eletricamente à pele e métodos e tratamentos relacionados aos mesmos

Country Status (8)

Country Link
EP (1) EP2561092A1 (pt)
JP (1) JP2013527756A (pt)
KR (1) KR20120137407A (pt)
CN (1) CN102869789B (pt)
BR (1) BR112012026870A2 (pt)
CA (1) CA2795671A1 (pt)
MX (1) MX2012012235A (pt)
WO (1) WO2011133538A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9671410B2 (en) 2011-01-16 2017-06-06 The Procter & Gamble Company Biomarker-based methods for identifying and formulating compositions that improve skin quality and reduce the visible signs of aging in skin
MX2013010977A (es) 2011-03-31 2013-10-30 Procter & Gamble Sistema, modelos y metodos para identificar y evaluar agentes dermoactivos eficaces para tratar la caspa/dermatitis seborreica.
JP2015512260A (ja) * 2012-03-30 2015-04-27 ザ プロクター アンド ギャンブルカンパニー 皮膚色素沈着用の剤を決定する際に使用するためのデータ・アーキテクチャの構築方法
MX2014014898A (es) 2012-06-06 2015-03-04 Procter & Gamble Sistemas y metodos de identificacion de agentes cosmeticos para composiciones para el cuidado del cabello/cuero cabelludo.
WO2014028568A1 (en) * 2012-08-15 2014-02-20 The Procter & Gamble Company Systems, models and methods for identifying and evaluating skin-active agents effective for treating an array of skin disorders
MX2017006148A (es) 2014-11-10 2017-07-27 Procter & Gamble Composiciones para el cuidado personal con dos fases beneficas.
WO2016077327A1 (en) 2014-11-10 2016-05-19 The Procter & Gamble Company Personal care compositions with two benefit phases
US10966916B2 (en) 2014-11-10 2021-04-06 The Procter And Gamble Company Personal care compositions
WO2019079405A1 (en) 2017-10-20 2019-04-25 The Procter & Gamble Company AEROSOL FOAMING CLEANSER FOR THE SKIN
WO2019079409A1 (en) 2017-10-20 2019-04-25 The Procter & Gamble Company CLEANER FOR AEROSOL MOUSSE FOAM
CN113015904A (zh) 2018-11-29 2021-06-22 宝洁公司 用于筛选个人护理产品的方法

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3755560A (en) 1971-06-30 1973-08-28 Dow Chemical Co Nongreasy cosmetic lotions
US4421769A (en) 1981-09-29 1983-12-20 The Procter & Gamble Company Skin conditioning composition
US5202231A (en) 1987-04-01 1993-04-13 Drmanac Radoje T Method of sequencing of genomes by hybridization of oligonucleotide probes
US5525464A (en) 1987-04-01 1996-06-11 Hyseq, Inc. Method of sequencing by hybridization of oligonucleotide probes
GB8810400D0 (en) 1988-05-03 1988-06-08 Southern E Analysing polynucleotide sequences
US5547839A (en) 1989-06-07 1996-08-20 Affymax Technologies N.V. Sequencing of surface immobilized polymers utilizing microflourescence detection
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US6040138A (en) 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
EP0430881A3 (en) 1989-11-29 1991-10-23 Ciba-Geigy Ag Photochromic compounds, process for their preparation and their use
US5288644A (en) 1990-04-04 1994-02-22 The Rockefeller University Instrument and method for the sequencing of genome
US5324633A (en) 1991-11-22 1994-06-28 Affymax Technologies N.V. Method and apparatus for measuring binding affinity
US5366443A (en) 1992-01-07 1994-11-22 Thapliyal And Eggers Partners Method and apparatus for advancing catheters through occluded body lumens
WO1993020236A1 (en) 1992-04-03 1993-10-14 Applied Biosystems, Inc. Probe composition and method
US5503980A (en) 1992-11-06 1996-04-02 Trustees Of Boston University Positional sequencing by hybridization
US5858659A (en) 1995-11-29 1999-01-12 Affymetrix, Inc. Polymorphism detection
US5470710A (en) 1993-10-22 1995-11-28 University Of Utah Automated hybridization/imaging device for fluorescent multiplex DNA sequencing
GB9401833D0 (en) 1994-02-01 1994-03-30 Isis Innovation Method for discovering ligands
US5458596A (en) 1994-05-06 1995-10-17 Dorsal Orthopedic Corporation Method and apparatus for controlled contraction of soft tissue
GB9507238D0 (en) 1995-04-07 1995-05-31 Isis Innovation Detecting dna sequence variations
US6430446B1 (en) 1995-05-05 2002-08-06 Thermage, Inc. Apparatus for tissue remodeling
US5755753A (en) 1995-05-05 1998-05-26 Thermage, Inc. Method for controlled contraction of collagen tissue
US6241753B1 (en) 1995-05-05 2001-06-05 Thermage, Inc. Method for scar collagen formation and contraction
US5660836A (en) 1995-05-05 1997-08-26 Knowlton; Edward W. Method and apparatus for controlled contraction of collagen tissue
US5661028A (en) 1995-09-29 1997-08-26 Lockheed Martin Energy Systems, Inc. Large scale DNA microsequencing device
US6228078B1 (en) 1995-11-22 2001-05-08 Arthrocare Corporation Methods for electrosurgical dermatological treatment
US6350276B1 (en) 1996-01-05 2002-02-26 Thermage, Inc. Tissue remodeling apparatus containing cooling fluid
AU2253397A (en) 1996-01-23 1997-08-20 Affymetrix, Inc. Nucleic acid analysis techniques
JP4102031B2 (ja) 1999-03-09 2008-06-18 サーメイジ インコーポレイテッド 組織を治療するのための装置および方法
US20020087155A1 (en) * 1999-08-30 2002-07-04 Underwood Ronald A. Systems and methods for intradermal collagen stimulation
US6702808B1 (en) 2000-09-28 2004-03-09 Syneron Medical Ltd. Device and method for treating skin
PT1331892E (pt) * 2000-10-18 2006-11-30 Mattioli Eng Ltd Método e aparelho para renovação de pele por plasma
US6889090B2 (en) 2001-11-20 2005-05-03 Syneron Medical Ltd. System and method for skin treatment using electrical current
US6662054B2 (en) 2002-03-26 2003-12-09 Syneron Medical Ltd. Method and system for treating skin
EP1558339A1 (en) 2002-10-07 2005-08-03 Palomar Medical Technologies, Inc. Apparatus for performing photobiostimulation
US7643883B2 (en) * 2005-01-28 2010-01-05 Syneron Medical Ltd. Device and method for treating skin
SI22738A (sl) * 2008-04-11 2009-10-31 Iskra Medical, D.O.O. Naprava za radiofrekvenčno krožno globinsko terapijo

Also Published As

Publication number Publication date
WO2011133538A1 (en) 2011-10-27
CA2795671A1 (en) 2011-10-27
CN102869789A (zh) 2013-01-09
MX2012012235A (es) 2012-11-23
KR20120137407A (ko) 2012-12-20
JP2013527756A (ja) 2013-07-04
CN102869789B (zh) 2015-09-30
EP2561092A1 (en) 2013-02-27

Similar Documents

Publication Publication Date Title
BR112012026870A2 (pt) assinaturas genéticas e chips de gene associados à administração de frequência de ráfsudio conduzida eletricamente à pele e métodos e tratamentos relacionados aos mesmos
AR093217A1 (es) Anticuerpos antagonistas mejorados contra factor-8 de crecimiento y diferenciacion y usos de los mismos
BR112014000949A2 (pt) aparelho para gerar ondas de impacto terapêuticas e aplicações do mesmo
CR20190034A (es) INHIBIDORES DE GLUCOSILCERAMIDA SINTASA (Divisional 2013-0471)
WO2012103315A3 (en) Apparatus and methods for treatment of obstructive sleep apnea utilizing cryolysis of adipose tissues
BR112013020798A2 (pt) terapia de combinação do inibidor mtor /jak
ES2721180T3 (es) Productos terapéuticos usando células adiposas y secreciones celulares
BR112015012295A8 (pt) Uso de um inibidor de wee1, e, kit para identificar um paciente com câncer
BR112014013661A2 (pt) Derivados de nucleosídeos 2’,4’-difluoro-2’-metil substituídos como inibidores de replicação de hcv-rna
NZ701715A (en) Means and methods for treating dlbcl
Peck et al. Cholesteryl esters: fueling the fury of prostate cancer
BR112014003071A2 (pt) tratamento de doença vascular periférica com o uso de células derivadas do tecido do cordão umbilical
BR112014020229A8 (pt) Métodos e composições relacionados a células tipo adiposas marrons
BR112015025292A2 (pt) método para operação de toda uma rede de suprimento de energia, onde a geração de energia é descentralizada
BR112016000874A2 (pt) vírus de rna oncolítico geneticamente estável, método de fabricação e uso dos mesmos
BR112012029546A2 (pt) processo para a produção de patches ou curativos de pele autóloga por meio de cultivo de queratinócitos e fibroblastos autólogos com soro autólogo para geração de pele
MX358726B (es) Biomarcador predictivo de supervivencia en el tratamiento de carcinoma de celulas renales.
BR112015021831A2 (pt) aparelho de stent e métodos de tratamento
BR112014004829A2 (pt) métodos de ativação da provocação das substâncias de geração de sinal encapsulado e mecanismo utilizando as substâncias de geração de sinal ativado
Kovacs et al. ACE2 drives dendritic cell function and neuroantigen specific immune responses
Leite et al. Watsu therapy in the treatment of fibromyalgia syndrome
Pu et al. An investigation of a new therapeutic target on atherosclerosis
Park et al. Prostaglandin E Stimulates Lung Fibroblasts Hepatocyte Growth Factor Release Through The EP2 Receptor
Lynch et al. miR-24 regulates p27 expression in prostate cancer
Chan et al. Lineage-Specific Functions of LKB1 in CML and B Lymphoid Blast Crisis

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law
B08G Application fees: restoration
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 8A ANUIDADE.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO ARQUIVAMENTO PUBLICADO NA RPI 2510 DE 12/02/2019.